Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Oak Ridge National Laboratory
- Rutgers University
- Pennsylvania State University
- Texas A&M University
- University of Kentucky
- University of Washington
- The Ohio State University
- NEW YORK UNIVERSITY ABU DHABI
- Nature Careers
- Princeton University
- Technical University of Denmark
- University of Utah
- Washington University in St. Louis
- Baylor College of Medicine
- KINGS COLLEGE LONDON
- National Renewable Energy Laboratory NREL
- University of North Carolina at Chapel Hill
- Bogazici University Center for Targeted Therapy Technologies
- Fred Hutchinson Cancer Center
- Georgia Southern University
- Institute for bioengineering of Catalonia, IBEC
- Lunds universitet
- Maastricht University (UM)
- Northeastern University
- Stanford University
- THE UNIVERSITY OF HONG KONG
- University of Colorado
- University of Florida
- University of Oxford
- University of South Carolina
- University of Southern California
- University of Texas at Dallas
- Aarhus University
- Argonne
- BENAJIBA team - INSERM U1342 - Saint-Louis Research Institute
- Bucknell University
- Carnegie Mellon University
- Chalmers University of Technology
- ETH Zürich
- Ghent University
- Harvard University
- Heidelberg University
- INSERM
- Institut Pasteur
- Jagiellonian University
- Josep Carreras Leukaemia Research Institute (IJC)
- King's College London
- Maastricht University (UM); yesterday published
- Medical College of Wisconsin
- RIKEN
- The University of Arizona
- UNIVERSITY OF VIENNA
- Universidade de Coimbra
- University of Basel
- University of Cambridge
- University of Chicago
- University of Gdańsk, Intercollegiate Faculty of Biotechnology
- University of Illinois at Chicago
- University of Minnesota
- University of North Texas at Dallas
- University of Oxford;
- University of Southern California (USC)
- University of Turku
- Université Marie et Louis Pasteur
- Université Paris Cité
- Utrecht University
- Vanderbilt University
- Åbo Akademi University
- Łukasiewicz Research Network - Krakow Institute of Technology
- 59 more »
- « less
-
Field
-
biologically/pharmaceutically important proteins for the treatment of cancer, stroke and other diseases. In addition, he/she will receive training in computational drug design, biochemistry and cell biology
-
important proteins for the treatment of cancer, stroke and other diseases. In addition, he/she will receive training in computational drug design, biochemistry and cell biology techniques for testing compound
-
formulations and how they cross biological barriers. They use new discoveries in drug delivery and barrier transport processes to design new diagnostic and drug administration systems. To date this work their
-
. They use new discoveries in drug delivery and barrier transport processes to design new diagnostic and drug administration systems. To date this work their work has been funded by 18 research grants with a
-
scientists, forming small teams focused on ambitious, ‘blue sky’ research for novel methods development relevant for drug discovery analysis pipelines, trial design and operational efficiency. Led by Professor
-
of new methods relevant for drug discovery analysis pipelines, trial design and operational efficiency. Other responsibilities will include helping with supervision of PhD students working on projects as
-
. We have multiple NIH-funded projects to study the influence of FDA-approved GLP-1R agonists on drug seeking and reinstatement in rodents. A newly funded NIH R01 has the goal to determine who may be
-
, a computational medicine scientist with expertise in mechanistic modeling and quantitative pharmacology, the lab is building innovative tools to accelerate clinical translation and support drug
-
have a high potential for translation towards treating a variety of neurologic and metabolic disorders. These approaches entail device design and manufacturing, drug conjugation, neuroscience, and
-
the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Our laboratory develops and exploits